Drug Firm To High Court: Confidential Patent Agreement Didn’t Affect On-Sale Date
WASHINGTON, D.C. — The existence of confidential licensing and purchase agreements with an investor did not result its pharmaceutical invention being “otherwise available to the public,” per the Leahy-Smith America Invents...To view the full article, register now.
Already a subscriber? Click here to view full article